- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2524-4426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Developing preclinical models of neuroblastoma: driving therapeutic testing ; volume:1 ; number:1 ; day:20 ; month:12 ; year:2019 ; pages:1-18 ; date:12.2019
BMC biomedical engineering ; 1, Heft 1 (20.12.2019), 1-18, 12.2019
- Urheber
-
Ornell, Kimberly J.
Coburn, Jeannine M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s42490-019-0034-8
- URN
-
urn:nbn:de:101:1-2020061120285925074617
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ornell, Kimberly J.
- Coburn, Jeannine M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Patient-derived xenografts as preclinical neuroblastoma models
Progressive neuroblastoma : innovation and novel therapeutic strategies
Emerging Neuroblastoma 3D In Vitro Models for Pre-Clinical Assessments
FGFR1 is a potential therapeutic target in neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
GPS driving: a digital biomarker for preclinical Alzheimer disease
Evaluation of FGFR1-4 as therapeutic targets in neuroblastoma
Prognostic and therapeutic relevance of TERT activation in neuroblastoma
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives
Epithelial to Mesenchymal Transition in Neuroblastoma: Mechanisms and Therapeutic Considerations
Patient-derived xenografts as preclinical neuroblastoma models
Progressive neuroblastoma : innovation and novel therapeutic strategies
Emerging Neuroblastoma 3D In Vitro Models for Pre-Clinical Assessments
FGFR1 is a potential therapeutic target in neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
GPS driving: a digital biomarker for preclinical Alzheimer disease
Evaluation of FGFR1-4 as therapeutic targets in neuroblastoma
Prognostic and therapeutic relevance of TERT activation in neuroblastoma
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives
Epithelial to Mesenchymal Transition in Neuroblastoma: Mechanisms and Therapeutic Considerations
Patient-derived xenografts as preclinical neuroblastoma models
Progressive neuroblastoma : innovation and novel therapeutic strategies
Emerging Neuroblastoma 3D In Vitro Models for Pre-Clinical Assessments
FGFR1 is a potential therapeutic target in neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
GPS driving: a digital biomarker for preclinical Alzheimer disease
Evaluation of FGFR1-4 as therapeutic targets in neuroblastoma
Prognostic and therapeutic relevance of TERT activation in neuroblastoma
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives